ArticleScientific reports2018

Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma.

Xuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.